Neurosafe: An expert's guide

Written by: Professor Greg Shaw
Published:
Edited by: Kate Forristal

 In his latest online article Professor Greg Shaw gives us his insights into NeuroSafe. He explains what it is, the benefits, the technique and how it has improved radical prostatectomy.

 

What is NeuroSAFE?

NeuroSAFE is a surgical technique that enables the surgeon to examine the prostate's surface for cancer cells during the operation. If cancer cells are detected on the surface, the surgeon can immediately remove additional tissue in the same procedure. This examination is conducted by promptly generating frozen section samples, which are then examined by a pathologist. If any further tissue removal is necessary, it can be performed while the patient is still under anaesthesia during the same operation.

 

What are the benefits of the NeuroSAFE technique?

MRI scans are effective in detecting prostate cancer, but they have limitations in precisely determining the cancer's boundaries. During radical prostatectomy, the surgeon's goal is to remove the outer layers of the prostate, which contain the delicate nerves responsible for erections and urine control. This process, known as nerve-sparing, greatly impacts the patient's post-surgery erectile function and urinary control. If the MRI indicates potential nerve involvement, nerve-sparing is avoided.

 

However, there are instances when the MRI results are overly cautious, leading to unnecessary removal of nerves that could be safely spared. The NeuroSAFE technique addresses this issue by providing the surgeon with additional certainty. It enables the identification and preservation of nerves that appear to be affected by cancer on the MRI without compromising the risk of leaving cancer cells behind. By using NeuroSAFE, the surgeon can optimize nerve-sparing, increasing the likelihood of satisfactory erectile function and quicker recovery of urinary control for the patient.

 

Is it safe?

The method appears to be safe. Having conducted more than 200 NeuroSAFE procedures, I've observed that the additional 45-60 minutes required for the analysis during the operation does not seem to lead to any extra complications.

 

What's involved in the NeuroSAFE technique?

The process entails close collaboration between the surgeon and a skilled team of technicians, responsible for preparing the samples for the pathologist's examination. The pathologist assesses the samples and communicates to the surgeon whether cancer cells are visible at the excised prostate's edge. If cancer cells are detected, the surgeon will proceed to remove the nerves on that side to minimize the risk of cancer cells being left behind. Fortunately, in the majority of cases, the pathologist's report confirms that the edge is clear, ensuring that the nerves have been successfully spared, and the patient's well-being is safeguarded.

 

How has the NeuroSAFE technique improved radical prostatectomy procedures?

 The NeuroSAFE procedure appears to be a secure approach to enhance the preservation of nerve tissue during radical prostatectomy. Preserving nerves is recognized to enhance a patient's chances of  recovering sexual function and urinary control after the procedure. As a leader in a national study, I am investigating the cost-effectiveness of implementing this technique within the NHS (neurosafeproof.com).

 

Professor Greg Shaw is a highly regarded consultant urological surgeon with over 20 years of experience. You can book an appointment with him today on his Top Doctor’s profile.

By Professor Greg Shaw
Urology

Professor Greg Shaw is a highly-respected and globally-recognised consultant urological surgeon based in London who specialises in prostate cancer, in particular robotic surgery, prostatectomy alongside urinary tract infection and urinary problems. He practises at The Prostate Centre, near Harley Street, while his NHS base is University College London Hospitals NHS Foundation Trust.

Professor Shaw is highly qualified with a BSc, MBBS and MD from the University of London, as well as an MRCS, FRCS (Urol) from the Royal College of Surgeons of England. After developing an interest in prostate cancer whilst undertaking his MD, he began his specialist urologist training in North London where he was awarded his urology fellowship.

Following this, he completed a four year lectureship at The University of Cambridge where he worked in a world-class research team, generated important research findings and was awarded a fellowship in robotic surgery.

Professor Shaw has performed over 1,100 robotic radical prostatectomies to date and strives to evaluate and incorporate the best technical modifications to attain excellent results. He prides himself in his very low complication rate.

Furthermore, he has developed several research collaborations including an enhanced recovery program for radical prostatectomy at his NHS base, safely increasing the number of patients being discharged home the day after robotic prostate removal. He also has developed and presented a novel surgical technique called complete urethral preservation during robotic assisted radical prostatectomy (RARP) which gives many patients immediate urinary continence.

Professor Shaw, who is a spokesperson for The Orchid Cancer Appeal, is a Professor of Urology at University of College London where he is leading the NeuroSAFE PROOF study to evaluate the cost effectiveness of the NeuroSAFE procedure during radical prostatectomy and the C-PRO-META study to evaluate the prognostic utility of circulating tumour cells in men undergoing surgery for prostate cancer. He has been awarded prizes for lectures delivered at international and national conferences, and one research project he conducted led to significant media interest including a front page article in The Daily Telegraph alongside global press coverage.

Professor Shaw's reputation clinical research also extends to his work as lead for Urology for the National Institute for Health Research (NIHR) for North Thames, while he was also involved in staff training for the NHS Nightingale Hospital in London. Furthermore he is a research consultant for the Royal College of Surgeons of England and has been a Clinical Studies Group member for the National Cancer Research Institute (NCRI).

Professor Shaw has published over 85 PubMed-linked papers, authored several book chapters and various other peer-reviewed articles. Furthermore he's the Associate Editor for uro-oncology for the British Journal of Urology International Knowledge project, where the team has developed an online curriculum supporting urology trainees and established consultants in their continued professional development.

Professor Shaw is a member of various professional organisations including the British Association of Urological Surgeons (BAUS), the European Association of Urology (EAU) and the Royal College of Surgeons of England.

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.